- Home
- CREV vs NURO Comparison
CREV vs NURO Comparison
Compare CREV & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- NURO
- Stock Information
- Founded
- CREV 2007
- NURO 1996
- Country
- CREV Ireland
- NURO United States
- Employees
- CREV N/A
- NURO N/A
- Industry
- CREV
- NURO Medical/Dental Instruments
- Sector
- CREV
- NURO Health Care
- Exchange
- CREV Nasdaq
- NURO Nasdaq
- Market Cap
- CREV 8.8M
- NURO 7.6M
- IPO Year
- CREV N/A
- NURO N/A
- Fundamental
- Price
- CREV $2.99
- NURO $3.93
- Analyst Decision
- CREV Strong Buy
- NURO
- Analyst Count
- CREV 1
- NURO 0
- Target Price
- CREV $39.00
- NURO N/A
- AVG Volume (30 Days)
- CREV 58.6K
- NURO 20.7K
- Earning Date
- CREV 01-01-0001
- NURO 11-05-2024
- Dividend Yield
- CREV N/A
- NURO N/A
- EPS Growth
- CREV N/A
- NURO N/A
- EPS
- CREV N/A
- NURO N/A
- Revenue
- CREV $39,261,077.00
- NURO $3,767,764.00
- Revenue This Year
- CREV $40.76
- NURO N/A
- Revenue Next Year
- CREV $86.18
- NURO N/A
- P/E Ratio
- CREV N/A
- NURO N/A
- Revenue Growth
- CREV 41.52
- NURO N/A
- 52 Week Low
- CREV $2.61
- NURO $2.66
- 52 Week High
- CREV $46.00
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- CREV 34.46
- NURO 50.39
- Support Level
- CREV $3.02
- NURO $3.56
- Resistance Level
- CREV $4.53
- NURO $3.80
- Average True Range (ATR)
- CREV 0.46
- NURO 0.32
- MACD
- CREV 0.02
- NURO -0.01
- Stochastic Oscillator
- CREV 19.80
- NURO 47.01
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.